ID: ALA3229681

Max Phase: Preclinical

Molecular Formula: C11H18N3O15P3

Molecular Weight: 525.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C11H18N3O15P3/c1-5(15)12-6-3-14(11(18)13-10(6)17)9-2-7(16)8(27-9)4-26-31(22,23)29-32(24,25)28-30(19,20)21/h3,7-9,16H,2,4H2,1H3,(H,12,15)(H,22,23)(H,24,25)(H,13,17,18)(H2,19,20,21)/t7-,8+,9+/m0/s1

Standard InChI Key:  HWFBWNSDJJEXPP-DJLDLDEBSA-N

Associated Targets(non-human)

Thymidine kinase, cytosolic 80 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 525.19Molecular Weight (Monoisotopic): 524.9951AlogP: -1.51#Rotatable Bonds: 9
Polar Surface Area: 273.24Molecular Species: ACIDHBA: 12HBD: 7
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 0.90CX Basic pKa: CX LogP: -3.55CX LogD: -10.97
Aromatic Rings: 1Heavy Atoms: 32QED Weighted: 0.18Np Likeness Score: 0.76

References

1. Hampton A, Kappler F, Chawla RR..  (1979)  Design of species- or isozyme-specific enzyme inhibitors. 1. Effect of thymidine substituents on affinity for the thymidine site of hamster cytoplasmic thymidine kinase.,  22  (6): [PMID:458818] [10.1021/jm00192a005]

Source